Covid-19 Incidence and Mortality by Age Strata and Comorbidities in Mexico City: A Focus in the Pediatric Population
- PMID: 34568267
- PMCID: PMC8459904
- DOI: 10.3389/fpubh.2021.738423
Covid-19 Incidence and Mortality by Age Strata and Comorbidities in Mexico City: A Focus in the Pediatric Population
Abstract
Background: SARS-COV2 appears less frequently and less severely in the pediatric population than in the older age groups. There is a need to precisely estimate the specific risks for each age group to design health and education policies suitable for each population. Objective: This study aimed to describe the risk of death in SARS-COV2 infected subjects by age group and according to the presence of comorbidities. Methods: We analyzed data of confirmed SARS-COV2 infection cases where symptoms began between February 22th, 2020, and April 18th, 2021, as published by the General Epidemiology Direction (DGE) of the Mexican Ministry of Health. We calculated COVID-19 incidence and mortality by age group using population data from the Statistics and Population National Institute (INEGI), and estimated the association between risk of death and the presence of comorbidities. Results: Mortality in SARS-COV2 infected people varied considerably, between 7 and 155 deaths per million per year in the under-20 age groups compared to 441 to 15,929 in the older age groups. Mortality in pediatric populations is strongly associated with comorbidities (OR: 4.6-47.9) compared to the milder association for older age groups (OR: 3.16-1.23). Conclusion: The risk of death from SARS-COV2 infection in children is low and is strongly associated with comorbidities.
Keywords: COVID-19; Case-Fatality Rate; Incidence; Mexico City; Mortality; SARS-COV2; children.
Copyright © 2021 González-García, Castilla-Peón, Solórzano Santos, Jiménez-Juárez, Martínez Bustamante, Minero Hibert and Garduño-Espinosa.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Survival analysis and mortality predictors of COVID-19 in a pediatric cohort in Mexico.Front Public Health. 2022 Dec 16;10:969251. doi: 10.3389/fpubh.2022.969251. eCollection 2022. Front Public Health. 2022. PMID: 36589967 Free PMC article.
-
Two-year follow-up of the COVID-19 pandemic in Mexico.Front Public Health. 2023 Jan 13;10:1050673. doi: 10.3389/fpubh.2022.1050673. eCollection 2022. Front Public Health. 2023. PMID: 36711379 Free PMC article.
-
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19. Lancet Infect Dis. 2021. PMID: 33091374 Free PMC article.
-
Assessing the Burden of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Mexico City: A Data-Driven Call to Action.Clin Infect Dis. 2021 Jul 1;73(1):e191-e198. doi: 10.1093/cid/ciaa1487. Clin Infect Dis. 2021. PMID: 32986819 Free PMC article.
-
Pediatric COVID-19: Systematic review of the literature.Am J Otolaryngol. 2020 Sep-Oct;41(5):102573. doi: 10.1016/j.amjoto.2020.102573. Epub 2020 Jun 6. Am J Otolaryngol. 2020. PMID: 32531620 Free PMC article.
Cited by
-
Lung Ultrasound Characteristics in Neonates With Positive Real Time Polymerase Chain Reaction for SARS-CoV-2 on a Tertiary Level Referral Hospital in Mexico City.Front Pediatr. 2022 Apr 8;10:859092. doi: 10.3389/fped.2022.859092. eCollection 2022. Front Pediatr. 2022. PMID: 35463891 Free PMC article.
-
Understanding the neurological implications of acute and long COVID using brain organoids.Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049. Epub 2023 Jul 17. Dis Model Mech. 2023. PMID: 37458167 Free PMC article. Review.
-
Epidemiological characterization of COVID-19 in children under 18 years old in Mexico: an analysis of the pandemic.Front Pediatr. 2025 Jan 7;12:1440107. doi: 10.3389/fped.2024.1440107. eCollection 2024. Front Pediatr. 2025. PMID: 39840319 Free PMC article.
-
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19. Clin Rev Allergy Immunol. 2023. PMID: 35044620 Free PMC article. Review.
-
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.Front Immunol. 2023 Aug 1;14:1228461. doi: 10.3389/fimmu.2023.1228461. eCollection 2023. Front Immunol. 2023. PMID: 37600800 Free PMC article. Clinical Trial.
References
-
- Galow LV, Haag L, Kahre E, Blankenburg J, Dalpke A, Lück C, et al. . Lower Household Transmission Rates of SARS-CoV-2 from Children Compared to Adults - Results from the FamilyCoviDD19-Study. SSRN Electron J [Internet]. (2021). Available online at: https://papers.ssrn.com/abstract=3790443 - PMC - PubMed
-
- Children and COVID-19: State-Level Data Report . (2021). Available from: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infect...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous